These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9693224)

  • 1. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
    Steiner T; Hacke W
    Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics.
    Chen SD; Lee JM; Yang DI; Nassief A; Hsu CY
    Am J Cardiovasc Drugs; 2002; 2(5):303-13. PubMed ID: 14727960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytics and neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident].
    Yepes MS
    Rev Neurol; 2001 Feb 1-15; 32(3):259-66. PubMed ID: 11310282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in cerebrovascular disease.
    Jain KK
    Expert Opin Investig Drugs; 2000 Apr; 9(4):695-711. PubMed ID: 11060703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic tolerance: a window to endogenous neuroprotection?
    Schaller B; Graf R; Jacobs AH
    Lancet; 2003 Sep; 362(9389):1007-8. PubMed ID: 14522526
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
    Davis M; Barer D
    Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in acute ischaemic stroke.
    Bhalla A; Rudd AG
    Int J Clin Pract; 1999 Jun; 53(4):295-300. PubMed ID: 10563075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of herbal drugs in cerebral ischemia.
    Gupta YK; Briyal S; Gulati A
    Indian J Physiol Pharmacol; 2010; 54(2):99-122. PubMed ID: 21090528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis and neuroprotection in cerebral ischemia. Future perspectives].
    Castillo J; Martínez-Vila E; Naveiro J; Vázquez C
    Rev Clin Esp; 1996 Nov; 196 Suppl 3():29-36. PubMed ID: 11000895
    [No Abstract]   [Full Text] [Related]  

  • 18. Limiting neurological damage after stroke: a review of pharmacological treatment options.
    Read SJ; Hirano T; Davis SM; Donnan GA
    Drugs Aging; 1999 Jan; 14(1):11-39. PubMed ID: 10069406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of acute cerebral ischemia.
    Biller J
    Neurol Clin; 1992 Feb; 10(1):63-85. PubMed ID: 1557010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.